Abstract
microRNAs (miRNAs) are small non-coding RNAs that regulate various biological processes. Cell-free miRNAs have been proposed as biomarkers of disease, including diagnosis, prognosis, and monitoring of treatment responses. These circulating miRNAs are highly stable in several body fluids, including plasma and serum; hence, in view of their potential use as novel, non-invasive biomarkers, the profiles of circulating miRNAs have been explored in the field of anti-doping. This chapter describes the enormous potential of circulating miRNAs as a new class of biomarkers for the detection of doping substances, and highlights the advantages of measuring these stable species over other methods that have already been implemented in anti-doping regimes. Incorporating longitudinal measurements of circulating miRNAs into the Athlete Biological Passport is proposed as an efficient strategy for the implementation of these new biomarkers. Furthermore, potential challenges related to the transition of measurements of circulating miRNAs from research settings to practical anti-doping applications are presented.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351–79; Epub 2010/06/11. eng.
Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597–610; Epub 2010/07/28. eng.
Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet. 2012;13(5):358–69; Epub 2012/04/19. eng.
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513–8; PMID: MID 18663219. eng.
Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108(12):5003–8; PMID: MID 21383194. eng.
Chevillet JR, Kang Q, Ruf IK, Briggs HA, Vojtech LN, Hughes SM, et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci U S A. 2014;111(41):14888–93; PMCID: 4205618.
Leuenberger N, Jan N, Pradervand S, Robinson N, Saugy M. Circulating microRNAs as long-term biomarkers for the detection of erythropoiesis-stimulating agent abuse. Drug Test Anal. 2011;3(11-12):771–6; Epub 2011/11/25. eng.
Kelly BN, Haverstick DM, Lee JK, Thorner MO, Vance ML, Xin W, et al. Circulating microRNA as a biomarker of human growth hormone administration to patients. Drug Test Anal. 2014;6(3):234–8. doi:10.1002/dta.1469; Epub 2013/03/16. Eng.
Leuenberger N, Schumacher YO, Pradervand S, Sander T, Saugy M, Pottgiesser T. Circulating microRNAs as biomarkers for detection of autologous blood transfusion. PLoS One. 2013;8(6), e66309.
McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem. 2011;57(6):833–40; PMID: MID 21487102. Eng.
Sottas PE, Vernec A. Current implementation and future of the Athlete Biological Passport. Bioanalysis. 2012;4(13):1645–52; Epub 2012/07/27. eng.
Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, Wrang Teilum M, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2013;59(1):S1–6; Epub 2012/10/06. eng.
Andreasen D, Fog JU, Biggs W, Salomon J, Dahslveen IK, Baker A, et al. Improved microRNA quantification in total RNA from clinical samples. Methods. 2010;50(4):S6–9; Epub 2010/03/11. eng.
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33(20), e179; PMCID: 1292995.
Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010;50(4):298–301; Epub 2010/02/12. eng.
Schwarzenbach H, Nishida N, Calin GA, Pantel K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol. 2014;11(3):145–56.
Schumacher YO, Saugy M, Pottgiesser T, Robinson N. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport. Drug Test Anal. 2012;4(11):846–53; Epub 2012/03/01. eng.
Pottgiesser T, Sottas PE, Echteler T, Robinson N, Umhau M, Schumacher YO. Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study. Transfusion. 2011;51(8):1707–15; Epub 2011/03/09. eng.
Robinson N, Sottas PE, Pottgiesser T, Schumacher YO, Saugy M. Stability and robustness of blood variables in an antidoping context. Int J Lab Hematol. 2011;33(2):146–53; Epub 2010/08/20. eng.
Leuenberger N, Robinson N, Saugy M. Circulating miRNAs: a new generation of anti-doping biomarkers. Anal Bioanal Chem. 2013;405(30):9617–23.
Grasedieck S, Sorrentino A, Langer C, Buske C, Dohner H, Mertens D, et al. Circulating microRNAs in hematological diseases: principles, challenges and perspectives. Blood. 2013;121:4977–84; Epub 2013/04/04. Eng.
Mraz M, Malinova K, Mayer J, Pospisilova S. MicroRNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun. 2009;390(1):1–4; Epub 2009/09/23. eng.
Schumacher YO, Wenning M, Robinson N, Sottas PE, Ruecker G, Pottgiesser T. Diurnal and exercise-related variability of haemoglobin and reticulocytes in athletes. Int J Sports Med. 2010;31(4):225–30; Epub 2010/02/12. eng.
Schumacher YO, Sahm D, Baumstark MW, Pottgiesser T. Reticulocytes in athletes: Longitudinal aspects and the influence of long- and short-term exercise. Drug Test Anal. 2010;2(10):469–74; Epub 2010/10/05. eng.
Baggish AL, Hale A, Weiner RB, Lewis GD, Systrom D, Wang F, et al. Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J Physiol. 2011;589(Pt 16):3983–94; PMCID: 3179997; Epub 2011/06/22. eng.
Nielsen S, Akerstrom T, Rinnov A, Yfanti C, Scheele C, Pedersen BK, et al. The miRNA plasma signature in response to acute aerobic exercise and endurance training. PLoS One. 2014;9(2), e87308; PMCID: 3929352.
Wu XD, Zeng K, Liu WL, Gao YG, Gong CS, Zhang CX, et al. Effect of aerobic exercise on miRNA-TLR4 signaling in atherosclerosis. Int J Sports Med. 2014;35(4):344–50.
Pareja-Galeano H, Sanchis-Gomar F, Garcia-Gimenez JL. Physical exercise and epigenetic modulation: elucidating intricate mechanisms. Sports Med. 2014;44(4):429–36.
Uhlemann M, Mobius-Winkler S, Fikenzer S, Adam J, Redlich M, Mohlenkamp S, et al. Circulating microRNA-126 increases after different forms of endurance exercise in healthy adults. Eur J Prev Cardiol. 2014;21(4):484–91.
Banzet S, Chennaoui M, Girard O, Racinais S, Drogou C, Chalabi H, et al. Changes in circulating microRNAs levels with exercise modality. J Appl Physiol. 2013;115(9):1237–44.
Kirby TJ, McCarthy JJ. MicroRNAs in skeletal muscle biology and exercise adaptation. Free Radic Biol Med. 2013;64:95–105.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Leuenberger, N., Saugy, M. (2015). Circulating microRNAs: The Future of Biomarkers in Anti-doping Field. In: Santulli, G. (eds) microRNA: Medical Evidence. Advances in Experimental Medicine and Biology, vol 888. Springer, Cham. https://doi.org/10.1007/978-3-319-22671-2_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-22671-2_20
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22670-5
Online ISBN: 978-3-319-22671-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)